» Articles » PMID: 10026157

Recruitment of the Retinoblastoma Protein to C-Jun Enhances Transcription Activity Mediated Through the AP-1 Binding Site

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1999 Feb 20
PMID 10026157
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The retinoblastoma susceptibility gene product (RB) is a transcriptional modulator. One of the targets for this modulator effect is the AP-1 binding site within the c-jun and collagenase promoters. The physical interactions between RB and c-Jun were demonstrated by co-immunoprecipitation of these two proteins using anti-c-Jun or anti-RB antisera, glutathione S-transferase affinity matrix binding assays in vitro, and electrophoretic mobility shift assays. The C-terminal site of the leucine zipper of c-Jun mediated the interaction with RB. Although the B-pocket domain of RB alone bound to c-Jun, a second c-Jun binding site in the RB was also suggested. Mammalian two-hybrid-based assay provided corroborative evidence that transactivation of gene expression by RB required the C-terminal region of c-Jun. We conclude that RB enhances transcription activity mediated through the AP-1 binding site. Adenovirus E1A or human papillomavirus E7 inhibits RB-mediated transcription activity. These data reveal that the interactions between these two distinct classes of oncoproteins RB and c-Jun may be involved in controlling cell growth and differentiation mediated by transcriptional regulation.

Citing Articles

Chromatin-bound RB targets promoters, enhancers, and CTCF-bound loci and is redistributed by cell-cycle progression.

Sanidas I, Lee H, Rumde P, Boulay G, Morris R, Golczer G Mol Cell. 2022; 82(18):3333-3349.e9.

PMID: 35981542 PMC: 9481721. DOI: 10.1016/j.molcel.2022.07.014.


RacGAP1 promotes the malignant progression of cervical cancer by regulating AP-1 via miR-192 and p-JNK.

Zhang T, Wang C, Wang K, Liang Y, Liu T, Feng L Cell Death Dis. 2022; 13(7):604.

PMID: 35831303 PMC: 9279451. DOI: 10.1038/s41419-022-05036-9.


CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity.

Watt A, Cejas P, DeCristo M, Metzger-Filho O, Lam E, Qiu X Nat Cancer. 2021; 2(1):34-48.

PMID: 33997789 PMC: 8115221. DOI: 10.1038/s43018-020-00135-y.


The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signalling.

Engstrom W, Darbre P, Eriksson S, Gulliver L, Hultman T, Karamouzis M Carcinogenesis. 2015; 36 Suppl 1:S38-60.

PMID: 26106143 PMC: 4565610. DOI: 10.1093/carcin/bgv030.


Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor α.

Barone I, Brusco L, Gu G, Selever J, Beyer A, Covington K J Natl Cancer Inst. 2011; 103(7):538-52.

PMID: 21447808 PMC: 3071355. DOI: 10.1093/jnci/djr058.